Stock Events

Stock Events

Halozyme Therapeutics (HTI) Q1 2026 Earnings

17FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.24

0.57

1.39

2.2

Details

Expected EPS

2.198

Actual EPS

-0.24

Surprise EPS

-2.44

Surprise Percent

+110.92%

Description

Halozyme Therapeutics (HTI) has reported earnings of -0.24 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.